Revenue
No reported data
CERO THERAPEUTICS HOLDINGS, INC. (CERO)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Research & development | — | $6.3M | $5.3M | — |
| Operating expenses | — | $15.3M | $7.7M | $2.9M |
| Operating income | — | −$15.3M | −$7.7M | −$2.9M |
| Net income | −$19.9M | −$7.7M | −$7.3M | −$667,736 |
| Basic EPSper diluted share | — | -$18.15 | -$1,248.64 | — |
| Diluted EPSper diluted share | — | -$18.15 | -$1,248.64 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 13, 2024Form 4 | YK Bioventures Opportunities GP I, LLC +3TenPercentOwner | SellCommon Stock · indirect | 3.00M | $0.06 | $179.9K | 13.01M |
| Dec 12, 2024Form 4 | YK Bioventures Opportunities GP I, LLC +3TenPercentOwner | SellCommon Stock · indirect | 1.61M | $0.07 | $113.0K | 16.00M |
| Dec 11, 2024Form 4 | YK Bioventures Opportunities GP I, LLC +3TenPercentOwner | SellCommon Stock · indirect | 1.34M | $0.08 | $107.5K | 17.62M |
| Dec 10, 2024Form 4 | Kossar Mitchell William +3TenPercentOwner | SellCommon Stock · indirect | 1.57M | $0.09 | $141.4K | 18.96M |
| Dec 9, 2024Form 4 | Kossar Mitchell William +3TenPercentOwner | SellCommon Stock · indirect | 850.5K | $0.11 | $93.6K | 20.53M |